ARTICLE | Company News
Osel, Miyarisan deal
March 7, 2005 8:00 AM UTC
Osel received exclusive North American and European commercialization rights to Miyarisan's MIYA-BM, a tablet that contains a strain of C. butyricum to treat and prevent antibiotic-induced gastrointe...